Development Back-up Compounds Clause Samples

Development Back-up Compounds. At such time as Celgene designates a Development Compound for a particular Target, Celgene shall, based upon the Clinical Candidate Guidelines and the results of the Discovery Program including the results of the Acute Tox Studies, designate for such Target up to two (2) Lead Compounds as Development Back-Up Compounds. Each such Back-up Compound so designated shall be deemed a “Development Back-Up Compound” for the purposes of this Agreement.